- Home
- CODA vs PROK Comparison
CODA vs PROK Comparison
Compare CODA & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODA
- PROK
- Stock Information
- Founded
- CODA 1994
- PROK 2015
- Country
- CODA United States
- PROK United States
- Employees
- CODA N/A
- PROK N/A
- Industry
- CODA Industrial Machinery/Components
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CODA Industrials
- PROK Health Care
- Exchange
- CODA Nasdaq
- PROK Nasdaq
- Market Cap
- CODA 92.5M
- PROK 94.9M
- IPO Year
- CODA N/A
- PROK N/A
- Fundamental
- Price
- CODA $6.77
- PROK $0.70
- Analyst Decision
- CODA Strong Buy
- PROK Buy
- Analyst Count
- CODA 1
- PROK 4
- Target Price
- CODA $11.00
- PROK $5.00
- AVG Volume (30 Days)
- CODA 46.1K
- PROK 1.2M
- Earning Date
- CODA 06-11-2025
- PROK 05-16-2025
- Dividend Yield
- CODA N/A
- PROK N/A
- EPS Growth
- CODA 61.24
- PROK N/A
- EPS
- CODA 0.34
- PROK N/A
- Revenue
- CODA $21,064,685.00
- PROK $76,000.00
- Revenue This Year
- CODA $11.64
- PROK N/A
- Revenue Next Year
- CODA $14.53
- PROK N/A
- P/E Ratio
- CODA $19.42
- PROK N/A
- Revenue Growth
- CODA 15.63
- PROK N/A
- 52 Week Low
- CODA $5.76
- PROK $0.46
- 52 Week High
- CODA $9.89
- PROK $4.44
- Technical
- Relative Strength Index (RSI)
- CODA 54.68
- PROK 41.42
- Support Level
- CODA $6.41
- PROK $0.94
- Resistance Level
- CODA $7.09
- PROK $0.77
- Average True Range (ATR)
- CODA 0.36
- PROK 0.12
- MACD
- CODA 0.04
- PROK -0.01
- Stochastic Oscillator
- CODA 65.03
- PROK 17.63
About CODA Coda Octopus Group Inc. Common stock
Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. It operates in two segments: Marine Technology Business and Marine Engineering Business. The Technology Business develops proprietary solutions for both the commercial and defense subsea market. Its solutions include hardware and software for Geophysical Systems, Motion & Positioning Systems, and Real-Time Volumetric Imaging Sonar. The Engineering Business segment provides engineering services to a range of clients in the defense markets. Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Marine Technology Business segment.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.